Your browser doesn't support javascript.
loading
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy.
Duan, Xiao-Peng; Liu, Ke; Jiao, Xiao-Dong; Qin, Bao-Dong; Li, Bing; He, Xi; Ling, Yan; Wu, Ying; Chen, Shi-Qi; Zang, Yuan-Sheng.
Afiliação
  • Duan XP; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Liu K; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Jiao XD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Qin BD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Li B; Burning Rock Biotech, Shanghai, China.
  • He X; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Ling Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Wu Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Chen SQ; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Zang YS; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Front Oncol ; 12: 1007146, 2022.
Article em En | MEDLINE | ID: mdl-36686739

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article